OVERVIEW

Rethinking Obesity in Adolescents is organized by Springer Healthcare IME.

About the Program:
Obesity in children and adolescents is at an all-time high. Adolescent obesity is likely to persist into adulthood, where it has more severe lifelong impact than adult-onset obesity, including a high risk of chronic comorbidities such as type 2 diabetes (T2D) and chronic kidney disease (CKD), alongside psychological distress.

Younger age at intervention is associated with improved long-term outcomes and a reduction in cardiometabolic risk, however compared with children, adolescents have a 41% lower chance of successful weight loss and maintenance, emphasizing the need for early, proactive, and sustained intervention and management.

The advent of anti-obesity medications (AOMs) has begun to close the gap between lifestyle intervention alone and bariatric surgery in terms of long-term weight management. With some of these AOMs now indicated in the adolescent population, we need to ensure the right people are benefiting from them.

This expert-led program aims to support you with the individualized management of obesity in adolescents through education on:

the importance of early detection and intervention;
how to develop tailored management plans including the appropriate incorporation of anti-obesity medications; and
managing the psychological and social factors influencing treatment adherence.

Learning objectives:
Following completion of this independent educational program, you will be able to:

Describe the chronic burden of obesity in adolescent and need for proactive intervention
Integrate pharmacological therapies alongside lifestyle interventions, where appropriate
Develop strategies to support individualized management strategies based on patient motivators and barriers